Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeted gene correction strategies.

P D Richardson1, B T Kren, C J Steer

  • 1Department of Medicine, University of Minnesota Medical School, Minneapolis 55455, USA.

Current Opinion in Molecular Therapeutics
|August 30, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Liver development is restored by blastocyst complementation of HHEX knockout in mice and pigs.

Stem cell research & therapy·2021
Same author

Ultrasound surveillance for hepatocellular carcinoma: service evaluation of a radiology-led recall system in a tertiary-referral centre for liver diseases in the UK.

Clinical radiology·2017
Same author

Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation.

Cell death & disease·2015
Same author

A classic collaboration: Michael Davies on plaque vulnerability.

Atherosclerosis·2011
Same author

Flow instability and wall shear stress variation in intracranial aneurysms.

Journal of the Royal Society, Interface·2009
Same author

Use of vibrational spectroscopy in defining the role of clathrin in coated vesicle formation.

Biophysical journal·2009
Same journal

Gene therapy: Have the risks associated with viral vectors been solved?

Current opinion in molecular therapeutics·2011
Same journal

Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.

Current opinion in molecular therapeutics·2010
Same journal

Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes.

Current opinion in molecular therapeutics·2010
Same journal

Corticorelin, a synthetic human corticotropin-releasing factor analog, for the treatment of peritumoral brain edema.

Current opinion in molecular therapeutics·2010
Same journal

Mogamulizumab, a humanized mAb against C-C chemokine receptor 4 for the potential treatment of T-cell lymphomas and asthma.

Current opinion in molecular therapeutics·2010
Same journal

Gevokizumab, an anti-IL-1β mAb for the potential treatment of type 1 and 2 diabetes, rheumatoid arthritis and cardiovascular disease.

Current opinion in molecular therapeutics·2010
See all related articles

Gene therapy is advancing with new delivery methods. This review focuses on gene repair strategies, differentiating them from gene augmentation and exploring their benefits.

Area of Science:

  • Genetics
  • Molecular Biology
  • Biotechnology

Background:

  • Gene therapy success is increasing due to growing knowledge of genetic diseases and improved delivery of therapeutic nucleic acids.
  • Gene therapy approaches are broadly categorized into gene replacement (or augmentation) and gene repair.
  • Gene augmentation involves delivering a functional gene copy, while gene repair targets the correction of specific mutations.

Purpose of the Study:

  • To review current gene repair strategies.
  • To differentiate between gene repair and gene augmentation.
  • To outline potential benefits and future developments in gene repair.

Main Methods:

  • Review of existing literature on gene repair strategies.
  • Comparative analysis of gene repair versus gene augmentation.

Related Experiment Videos

  • Discussion of in situ gene correction advantages.

    • Main Results:

    • Gene repair offers distinct advantages over gene augmentation by directly correcting mutations.
    • Various strategies for in situ gene repair are currently available.
    • The potential benefits of correction over augmentation are significant.

    Conclusions:

    • Gene repair represents a promising frontier in genetic medicine.
    • Further developments in gene repair strategies could revolutionize treatment for genetic disorders.
    • The focus on in situ correction offers a more precise therapeutic approach.